Tue, Jun 30, 8:00 AM, Zacks
Juno-Celgene in Immunotherapy Deal, Initial Deal Value $1B - Analyst Blog
Juno (JUNO) has signed a collaboration agreement with Celgene (CELG) worth at least $1 billion.
Thu, Jun 25, 2:25 PM, Zacks
Agios Doses First Patient with AG-881 in Early-Stage Study - Analyst Blog
Agios (AGIO) dosed the first patient with AG-881 in a phase I study for advanced solid tumors with an IDH mutation.